Co Diagnostics Inc (CODX)

Finanzdaten der Co Diagnostics Inc-Aktie (CODX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	13.82%0.17	0.15	0.26	0.15	0.16
Cost Of Revenue	76.62%0.05	0.19	0.14	0.03	0.03
Gross Profit	352.70%0.12	-0.05	0.12	0.12	0.13
	30.99%6.32	9.16	26.66	7.13	8.19
Research and Development	30.03%4.15	5.93	5.10	4.48	4.69
Depreciation and Amortization	20.98%0.20	0.26	0.27	0.27	0.29
Operating Income/Loss	32.66%-6.20	-9.21	-26.54	-7.01	-8.06
Nonoperating Income/Loss	192.66%-0.06	0.07	0.32	-0.04	0.34
Income/Loss From Continuing Operations Before Tax	31.46%-6.26	-9.14	-26.22	-7.05	-7.72
Income Tax Expense/Benefit	3,586%0.02	0.00	-0.47	-1.17	0.01
	31.25%-6.28	-9.14	-25.75	-5.89	-7.73
Attributable To Parent	31.25%-6.28	-9.14	-25.75	-5.89	-7.73
Basic Average Shares	91.26%4.31	2.25	-	37.89	33.11
Diluted Average Shares	91.26%4.31	2.25	-	37.89	33.11
Basic Earnings Per Share	64.04%-1.46	-4.06	-	-0.16	-0.23
Diluted Earnings Per Share	64.04%-1.46	-4.06	-	-0.16	-0.23